Abstract
Introduction: The treatment of patients with glossopharyngeal neuralgia (GN) refractory to medical therapies is challenging. Gamma knife radiosurgery (GKRS) has emerged as an incisionless treatment option with outcomes reported in a limited number of studies. The aim of this study was to report on the outcomes of GKRS in patients with GN treated at our center. Methods: We retrospectively reviewed all patients with GN who underwent GKRS at our center since 2017. Pain intensity was evaluated using the Barrow Neurological Institute (BNI) pain score modified for GN. Adverse events were recorded. Results: Six patients underwent GKRS for GN at our center between 2017 and 2024. The maximum dose delivered was 85 Gy for 1 patient and 90 Gy for the others. After a median period of 2 weeks from GKRS, all patients experienced pain reduction (BNI I-IIIa). Pain recurred during follow-up in 2 patients after 9 and 3 months, respectively. Both underwent repeat GKRS, which relieved pain in one. No adverse event or neurological deficit occurred. Conclusions: GKRS is an effective, well-tolerated treatment for patients with GN. Pain may recur over time, but more durable pain relief can be achieved with repeat GKRS.
Journal Section:
Clinical Study
References
1.
Pearce
JM
. Glossopharyngeal neuralgia
. Eur Neurol
. 2006
;55
(1
):49
–52
. 2.
Franzini
A
, Messina
G
, Franzini
A
, Marchetti
M
, Ferroli
P
, Fariselli
L
, et al. Treatments of glossopharyngeal neuralgia: towards standard procedures
. Neurol Sci
. 2017
;38
(Suppl 1
):51
–5
. 3.
Franzini
A
, Moosa
S
, D’Ammando
A
, Bono
B
, Scheitler-Ring
K
, Ferroli
P
, et al. The neurosurgical treatment of craniofacial pain syndromes: current surgical indications and techniques
. Neurol Sci
. 2019
;40
(Suppl 1
):159
–68
. 4.
Shah
RJ
, Padalia
D
. Glossopharyngeal neuralgia
. In: Disclosure: devang Padalia declares no relevant financial relationships with ineligible companies
; Treasure Island (FL)
: Ineligible companies. StatPearls
; 2024
.5.
Ferroli
P
, Fioravanti
A
, Schiariti
M
, Tringali
G
, Franzini
A
, Calbucci
F
, et al. Microvascular decompression for glossopharyngeal neuralgia: a long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases
. Acta Neurochir
. 2009
;151
(10
):1245
–50
. 6.
Xiong
NX
, Zhao
HY
, Zhang
FC
, Liu
RE
. Vagoglossopharyngeal neuralgia treated by microvascular decompression and glossopharyngeal rhizotomy: clinical results of 21 cases
. Stereotact Funct Neurosurg
. 2012
;90
(1
):45
–50
. 7.
Balossier
A
, Tuleasca
C
, Muracciole
X
, Donnet
A
, Levivier
M
, Régis
J
. The outcomes of a second and third Gamma Knife radiosurgery for recurrent essential glossopharyngeal neuralgia
. Acta Neurochir
. 2020
;162
(2
):271
–7
. 8.
Borius
PY
, Tuleasca
C
, Muraciole
X
, Negretti
L
, Schiappacasse
L
, Dorenlot
A
, et al. Gamma Knife radiosurgery for glossopharyngeal neuralgia: a study of 21 patients with long-term follow-up
. Cephalalgia
. 2018
;38
(3
):543
–50
. 9.
Chai
S
, Xu
H
, Xiao
D
, Wang
J
, Wang
Y
, Li
J
, et al. Salvage gamma knife surgery for recurrent glossopharyngeal neuralgia following microvascular decompression: a retrospective case series
. Acta Neurochir
. 2021
;163
(4
):1021
–6
. 10.
Héroux
F
, Mathieu
D
. Treatment of glossopharyngeal neuralgia by gamma knife radiosurgery
. Can J Neurol Sci
. 2015
;42
(5
):350
–2
. 11.
Iwai
Y
, Ishibashi
K
, Yamanaka
K
. Gamma knife radiosurgery for concurrent trigeminal neuralgia and glossopharyngeal neuralgia
. Cureus
. 2021
;13
(12
):e20717
. 12.
Kano
H
, Urgosik
D
, Liscak
R
, Pollock
BE
, Cohen-Inbar
O
, Sheehan
JP
, et al. Stereotactic radiosurgery for idiopathic glossopharyngeal neuralgia: an international multicenter study
. J Neurosurg
. 2016
;125
(Suppl 1
):147
–53
. 13.
Kaye
J
, Daggubati
LC
, Zeller
S
, McInerney
J
. Repeat gamma knife radiosurgery for recurrent glossopharyngeal neuralgia: a systematic review and our initial experience
. Stereotact Funct Neurosurg
. 2020
;98
(5
):324
–30
. 14.
Lara-Almunia
M
, Moreno
NEM
, Sarraga
JG
, Alvarez
RM
. Gamma Knife radiosurgery and refractory glossopharyngeal neuralgia: a single-center series with long-term follow-up
. Neurosurg Rev
. 2022
;45
(1
):525
–31
. 15.
Lévêque
M
, Park
MC
, Melhaoui
A
, Yomo
S
, Donnet
A
, Régis
J
. Gamma knife radiosurgery for glossopharyngeal neuralgia: Marseille experience
. J Radiosurg SBRT
. 2011
;1
(1
):41
–6
.16.
Martínez-Álvarez
R
, Martínez-Moreno
N
, Kusak
ME
, Rey-Portolés
G
. Glossopharyngeal neuralgia and radiosurgery
. J Neurosurg
. 2014
;121
(Suppl l
):222
–5
. 17.
O'Connor
JK
, Bidiwala
S
. Effectiveness and safety of Gamma Knife radiosurgery for glossopharyngeal neuralgia
. Proc
. 2013
;26
(3
):262
–4
. 18.
Pollock
BE
, Boes
CJ
. Stereotactic radiosurgery for glossopharyngeal neuralgia: preliminary report of 5 cases
. J Neurosurg
. 2011
;115
(5
):936
–9
. 19.
Pommier
B
, Touzet
G
, Lucas
C
, Vermandel
M
, Blond
S
, Reyns
N
. Glossopharyngeal neuralgia treated by Gamma Knife radiosurgery: safety and efficacy through long-term follow-up
. J Neurosurg
. 2018
;128
(5
):1372
–9
. 20.
Samanci
Y
, Mürdün
E
, Çil
M
, Düzkalir
AH
, Askeroglu
MO
, Peker
S
. Long-term outcomes of Gamma Knife radiosurgery in treating glossopharyngeal neuralgia
. Headache
. 2024
;64
(3
):323
–8
. 21.
Stanic
S
, Franklin
SD
, Pappas
CT
, Stern
RL
. Gamma knife radiosurgery for recurrent glossopharyngeal neuralgia after microvascular decompression
. Stereotact Funct Neurosurg
. 2012
;90
(3
):188
–91
. 22.
Stieber
VW
, Bourland
JD
, Ellis
TL
. Glossopharyngeal neuralgia treated with gamma knife surgery: treatment outcome and failure analysis. Case report
. J Neurosurg
. 2005
;102
(Suppl l
):155
–7
. 23.
Williams
BJ
, Schlesinger
D
, Sheehan
J
. Glossopharyngeal neuralgia treated with gamma knife radiosurgery
. World Neurosurg
. 2010
;73
(4
):413
–7
. 24.
Xiong
NX
, Tan
D
, Fu
P
, Zhao
HY
. Gamma knife radiosurgery for glossopharyngeal neuralgia by targeting the medial cisternal segment of the glossopharyngeal nerve: report of 3 cases
. Stereotact Funct Neurosurg
. 2015
;93
(4
):292
–6
. 25.
Yomo
S
, Arkha
Y
, Donnet
A
, Régis
J
. Gamma Knife surgery for glossopharyngeal neuralgia
. J Neurosurg
. 2009
;110
(3
):559
–63
. 26.
Arnold
M
. Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders
. Cephalalgia
. 2018
;38
(1
):1
–211
.27.
Rogers
CL
, Shetter
AG
, Fiedler
JA
, Smith
KA
, Han
PP
, Speiser
BL
. Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of the Barrow Neurological Institute
. Int J Radiat Oncol Biol Phys
. 2000
;47
(4
):1013
–9
. 28.
Rey-Dios
R
, Cohen-Gadol
AA
. Current neurosurgical management of glossopharyngeal neuralgia and technical nuances for microvascular decompression surgery
. Neurosurg Focus
. 2013
;34
(3
):E8
. 29.
Lu
VM
, Goyal
A
, Graffeo
CS
, Perry
A
, Jonker
BP
, Link
MJ
. Glossopharyngeal neuralgia treatment outcomes after nerve section, microvascular decompression, or stereotactic radiosurgery: a systematic review and meta-analysis
. World Neurosurg
. 2018
;120
:572
–82.e7
. 30.
Spina
A
, Boari
N
, Gagliardi
F
, Bailo
M
, Morselli
C
, Iannaccone
S
, et al. The emerging role of gamma knife radiosurgery in the management of glossopharyngeal neuralgia
. Neurosurg Rev
. 2019
;42
(1
):31
–8
. 31.
Tuleasca
C
, Carron
R
, Resseguier
N
, Donnet
A
, Roussel
P
, Gaudart
J
, et al. Decreased probability of initial pain cessation in classic trigeminal neuralgia treated with gamma knife surgery in case of previous microvascular decompression: a prospective series of 45 patients with >1 Year of follow-up
. Neurosurgery
. 2015
;77
(1
):87
–95
; discussion -5. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
